ROSE-AHF and lessons learned
- PMID: 24966060
- PMCID: PMC4151258
- DOI: 10.1007/s11897-014-0208-6
ROSE-AHF and lessons learned
Abstract
Nesiritide and dopamine have been recognized for some time as potential renal adjunct therapies in the management of patients with acute heart failure (AHF). Several studies have yielded conflicting evidence of the efficacy of both medications in enhancing the renal function of patients with AHF. The Renal Optimization Strategies Evaluation (ROSE) study was a multicenter double-blind placebo controlled trial designed to assess the potential renoprotective effects of low-dose nesiritide and dopamine in AHF patients with renal dysfunction. This article will focus on previous research, summary of results, and lessons learned from the ROSE-AHF trial as well as future directions for clinical research and applications.
Conflict of interest statement
Amit K. Jain declares that he has no conflict of interest.
Horng H. Chen has received financial support through grants from the National Institutes of Health (NIH) and Scios, Inc.; has received royalties from Nile Therapeutics, Anexon, and UpToDate; holds the patent issued for chimeric natriuretic peptides; and is the co-founder of Zumbro Discovery.
Similar articles
-
Differential Response to Low-Dose Dopamine or Low-Dose Nesiritide in Acute Heart Failure With Reduced or Preserved Ejection Fraction: Results From the ROSE AHF Trial (Renal Optimization Strategies Evaluation in Acute Heart Failure).Circ Heart Fail. 2016 Aug;9(8):10.1161/CIRCHEARTFAILURE.115.002593 e002593. doi: 10.1161/CIRCHEARTFAILURE.115.002593. Circ Heart Fail. 2016. PMID: 27512103 Free PMC article. Clinical Trial.
-
Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial.JAMA. 2013 Dec 18;310(23):2533-43. doi: 10.1001/jama.2013.282190. JAMA. 2013. PMID: 24247300 Free PMC article. Clinical Trial.
-
Is there still a role for low-dose dopamine use in acute heart failure?Curr Opin Crit Care. 2014 Oct;20(5):467-71. doi: 10.1097/MCC.0000000000000133. Curr Opin Crit Care. 2014. PMID: 25137402 Review.
-
Assessment of dyspnea in acute decompensated heart failure: insights from ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure) on the contributions of peak expiratory flow.J Am Coll Cardiol. 2012 Apr 17;59(16):1441-8. doi: 10.1016/j.jacc.2011.11.061. J Am Coll Cardiol. 2012. PMID: 22497823 Clinical Trial.
-
Controversy and conflict in the treatment of acute decompensated heart failure: nesiritide as evidence-based treatment.Pharmacotherapy. 2007 May;27(5):619-25. doi: 10.1592/phco.27.5.619. Pharmacotherapy. 2007. PMID: 17461695 Review.
Cited by
-
Natriuretic Response Is Highly Variable and Associated With 6-Month Survival: Insights From the ROSE-AHF Trial.JACC Heart Fail. 2019 May;7(5):383-391. doi: 10.1016/j.jchf.2019.01.007. JACC Heart Fail. 2019. PMID: 31047017 Free PMC article.
-
Acute kidney injury in acute heart failure-when to worry and when not to worry?Nephrol Dial Transplant. 2024 Dec 20;40(1):10-18. doi: 10.1093/ndt/gfae146. Nephrol Dial Transplant. 2024. PMID: 38944413 Free PMC article. Review.
-
The dark side of the kidney in cardio-renal syndrome: renal venous hypertension and congestive kidney failure.Heart Fail Rev. 2018 Mar;23(2):291-302. doi: 10.1007/s10741-018-9673-4. Heart Fail Rev. 2018. PMID: 29383636 Review.
-
Differential effects of inotropes and inodilators on renal function in acute cardiac care.Eur Heart J Suppl. 2020 May;22(Suppl D):D12-D19. doi: 10.1093/eurheartj/suaa091. Epub 2020 May 15. Eur Heart J Suppl. 2020. PMID: 32431569 Free PMC article.
References
-
- Damman K, et al. Worsening Renal Function and Prognosis in Heart Failure: Systematic Review and Meta-Analysis. Journal of Cardiac Failure. 2007;13(8):599–608. - PubMed
-
- Udelson JE. Heart Failure With Preserved Ejection Fraction. Circulation. 2011;124(21):e540–e543. - PubMed
-
- Chen HH, et al. Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial. Jama. 2013;310(23):2533–43. Studied low dose dopamine and nesiritide in the treatment of acute heart failure patients demonstrating now significant renoprotective benefit of either drug with subgroup analysis showing possible benefit in HF-rEF with nesiritide. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
